JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 24, 2005; DOI: 10.1124/jpet.105.089490


0022-3565/05/3152-576-589$20.00
JPET 315:576-589, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.089490v1
315/2/576    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawao, N.
Right arrow Articles by Kawabata, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawao, N.
Right arrow Articles by Kawabata, A.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Signal Transduction for Proteinase-Activated Receptor-2-Triggered Prostaglandin E2 Formation in Human Lung Epithelial Cells

Naoyuki Kawao, Mami Nagataki, Keita Nagasawa, Satoko Kubo, Kelly Cushing, Tetsuyuki Wada, Fumiko Sekiguchi, Seiji Ichida, Morley D. Hollenberg, Wallace K. MacNaughton, Hiroyuki Nishikawa, and Atsufumi Kawabata

Division of Physiology and Pathophysiology (N.K., M.N., K.N., S.K., F.S., A.K.) and Division of Biological Chemistry (T.W., S.I.), School of Pharmaceutical Sciences, Kinki University, Higashi-Osaka, Japan; Department of Pharmacology and Therapeutics (M.D.H.) and Department of Physiology and Biophysics (K.C., W.K.M.), Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada; and Research and Development Centre, Fuso Pharmaceutical Industries Ltd., Osaka, Japan (H.N.)

We investigated proteinase-activated receptor-2 (PAR2)-triggered signal transduction pathways causing increased prostaglandin E2 (PGE2) formation in human lung-derived A549 epithelial cells. The PAR2 agonist, SLIGRL-NH2 (Ser-Leu-Ile-Gly-Arg-Leu-amide), evoked immediate cytosolic Ca2+ mobilization and delayed (0.5-3 h) PGE2 formation. The PAR2-triggered PGE2 formation was attenuated by inhibition of the following signal pathway enzymes: cyclooxygenases 1 and 2 (COX-1 and COX-2, respectively), cytosolic Ca2+-dependent phospholipase A2 (cPLA2), the mitogen-activated protein kinases (MAPKs), mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK)-extracellular signal-regulated kinase (ERK) and p38 MAPK, Src family tyrosine kinase, epidermal growth factor (EGF) receptor tyrosine kinase (EGFRK), and protein kinase C (PKC), but not by inhibition of matrix metalloproteinases. SLIGRL-NH2 caused prompt (5 min) and transient ERK phosphorylation, blocked in part by inhibitors of PKC and tyrosine kinases but not by an EGFRK inhibitor. SLIGRL-NH2 also evoked a relatively delayed (15 min) and persistent (30 min) phosphorylation of p38 MAPK, blocked by inhibitors of Src and EGFRK but not by inhibitors of COX-1 or COX-2. SLIGRL-NH2 elicited a Src inhibitor-blocked prompt (5 min) and transient phosphorylation of the EGFRK. SLIGRL-NH2 up-regulated COX-2 protein and/or mRNA levels that were blocked by inhibition of p38 MAPK, EGFRK, Src, and COX-2 but not MEK-ERK. SLIGRL-NH2 also caused COX-1-dependent up-regulation of microsomal PGE synthase-1 (mPGES-1). We conclude that PAR2-triggered PGE2 formation in A549 cells involves a coordinated up-regulation of COX-2 and mPGES-1 involving cPLA2, increased cytosolic Ca2+, PKC, Src, MEK-ERK, p38 MAPK, Src-mediated EGF receptor trans-activation, and also metabolic products of both COX-1 and COX-2.


Received for publication May 13, 2005
Accepted August 23, 2005.

Address correspondence to: Dr. Atsufumi Kawabata, Division of Physiology and Pathophysiology, School of Pharmaceutical Sciences, Kinki University, 3-4-1 Kowakae, Higashi-Osaka 577-8502, Japan. E-mail: kawabata{at}phar.kindai.ac.jp




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Z.-Y. Wang, P. Wang, and D. E. Bjorling
Role of mast cells and protease-activated receptor-2 in cyclooxygenase-2 expression in urothelial cells
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2009; 297(4): R1127 - R1135.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Morla, G. Crambert, D. Mordasini, G. Favre, A. Doucet, and M. Imbert-Teboul
Proteinase-activated Receptor 2 Stimulates Na,K-ATPase and Sodium Reabsorption in Native Kidney Epithelium
J. Biol. Chem., October 17, 2008; 283(42): 28020 - 28028.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. M. Saleh, T. S. Mann, T. Peters, R. J. Betts, and P. J. Henry
Influence of Dexamethasone on Protease-Activated Receptor 2-Mediated Responses in the Airways
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 622 - 630.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Q. van der Merwe, M. D. Hollenberg, and W. K. MacNaughton
EGF receptor transactivation and MAP kinase mediate proteinase-activated receptor-2-induced chloride secretion in intestinal epithelial cells
Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G441 - G451.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Wang, S. Wen, N. W. Bunnett, R. Leduc, M. D. Hollenberg, and W. K. MacNaughton
Proteinase-activated Receptor-2 Induces Cyclooxygenase-2 Expression through -Catenin and Cyclic AMP-response Element-binding Protein
J. Biol. Chem., January 11, 2008; 283(2): 809 - 815.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Ostrowska, E. Sokolova, and G. Reiser
PAR-2 activation and LPS synergistically enhance inflammatory signaling in airway epithelial cells by raising PAR expression level and interleukin-8 release
Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1208 - L1218.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.